Edwards Lifesciences executive sells 583 shares at $86.01

Edwards Lifesciences Corp executive reports small stock sale An officer of Edwards Lifesciences Corp, serving as CVP, JAPAC, reported a routine sale of company stock.

Accepted by SEC EDGAR 12/08/2025 - 05:50 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Edwards Lifesciences Corp executive reports small stock sale

An officer of Edwards Lifesciences Corp, serving as CVP, JAPAC, reported a routine sale of company stock. On 12/08/2025, the reporting person sold 583 shares of Edwards Lifesciences common stock at a price of $86.01 per share. After this transaction, the insider reported beneficial ownership of 17,562.8708 shares of common stock, held directly. The filing notes that it reflects changes in beneficial ownership only and does not identify any other securities of Edwards Lifesciences that may be beneficially owned by this person.

Insider Trade Summary

Net Seller: 583 shares

Net Sell 1 txn

Insider Markowitz Wayne

Role CVP, JAPAC

Sold 583 shs ($50K)

Type	Security	Shares	Price	Value
Sale	Common Stock	583	$86.01	$50K

Holdings After Transaction: Common Stock — 17,562.8708 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Edwards Lifesciences (EW) report in this Form 4?

The filing reports that an officer of Edwards Lifesciences Corp sold 583 shares of common stock on 12/08/2025.

At what price were Edwards Lifesciences (EW) shares sold in this insider transaction?

The insider sold the 583 shares of Edwards Lifesciences common stock at a price of $86.01 per share.

How many Edwards Lifesciences (EW) shares does the insider own after this transaction?

Following the reported sale, the insider beneficially owns 17,562.8708 shares of Edwards Lifesciences common stock, held directly.

What is the insider’s role at Edwards Lifesciences (EW)?

The reporting person is an officer of Edwards Lifesciences Corp with the title CVP, JAPAC.

Does this Form 4 cover all securities the insider owns in Edwards Lifesciences (EW)?

No. The remarks state that the form reflects changes in beneficial ownership only and does not identify other securities of the issuer that may be beneficially owned.

Is this Edwards Lifesciences (EW) Form 4 filed for one person or multiple reporting persons?

The document indicates that the Form is filed by one reporting person, not by more than one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Markowitz Wayne

(Last) (First) (Middle)

ONE EDWARDS WAY

(Street)

IRVINE CA 92614

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Edwards Lifesciences Corp [ EW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CVP, JAPAC

3. Date of Earliest Transaction (Month/Day/Year)
12/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/08/2025		S		583	D	$86.01	17,562.8708	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

	Linda J. Park, Attorney-in-Fact	12/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.